Nykode Therapeutics (Norway) Probability of Future Stock Price Finishing Under 0.03
| NYKD Stock | 3.26 0.03 0.91% |
Nykode |
Nykode Therapeutics Target Price Odds to finish below 0.03
The tendency of Nykode Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 0.03 or more in 90 days |
| 3.26 | 90 days | 0.03 | near 1 |
Based on a normal probability distribution, the odds of Nykode Therapeutics to drop to 0.03 or more in 90 days from now is near 1 (This Nykode Therapeutics ASA probability density function shows the probability of Nykode Stock to fall within a particular range of prices over 90 days) . Probability of Nykode Therapeutics ASA price to stay between 0.03 and its current price of 3.26 at the end of the 90-day period is about 22.18 .
Assuming the 90 days trading horizon Nykode Therapeutics ASA has a beta of -0.69. This indicates as returns on the benchmark increase, returns on holding Nykode Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Nykode Therapeutics ASA is likely to outperform the market. Additionally Nykode Therapeutics ASA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Nykode Therapeutics Price Density |
| Price |
Predictive Modules for Nykode Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nykode Therapeutics ASA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Nykode Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Nykode Therapeutics is not an exception. The market had few large corrections towards the Nykode Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Nykode Therapeutics ASA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Nykode Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.42 | |
β | Beta against Dow Jones | -0.69 | |
σ | Overall volatility | 1.15 | |
Ir | Information ratio | -0.09 |
Nykode Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nykode Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nykode Therapeutics ASA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nykode Therapeutics generated a negative expected return over the last 90 days | |
| Nykode Therapeutics has high historical volatility and very poor performance |
Nykode Therapeutics Technical Analysis
Nykode Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Nykode Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nykode Therapeutics ASA. In general, you should focus on analyzing Nykode Stock price patterns and their correlations with different microeconomic environments and drivers.
Nykode Therapeutics Predictive Forecast Models
Nykode Therapeutics' time-series forecasting models is one of many Nykode Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Nykode Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Nykode Therapeutics ASA
Checking the ongoing alerts about Nykode Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Nykode Therapeutics ASA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Nykode Therapeutics generated a negative expected return over the last 90 days | |
| Nykode Therapeutics has high historical volatility and very poor performance |